Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell–cell adhesion and signaling mechanism that requires cis-trans receptor clustering
K. F. Stengel , K. Harden-Bowles , X. Yu , L. Rouge
Proceedings of the National Academy of Sciences of the United States of America 109 ( 14) 5399 -5404
177
2012
G-protein-coupled receptor oligomers: two or more for what? Lessons from mGlu and GABAB receptors
J.-P. Pin , L. Comps-Agrar , D. Maurel , C. Monnier
The Journal of Physiology 587 ( 22) 5337 -5344
50
2009
Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109.
A. E. Fouts , L. Comps-Agrar , K. F. Stengel , D. Ellerman
Proceedings of the National Academy of Sciences of the United States of America 111 ( 22) 8209 -8214
40
2014
Stability of GABAB receptor oligomers revealed by dual TR-FRET and drug-induced cell surface targeting
Laëtitia Comps‐Agrar , Julie Kniazeff , Carsten Brock , Eric Trinquet
The FASEB Journal 26 ( 8) 3430 -3439
40
2012
Dimeric functioning of metabotropic glutamate receptors
JP Pin , D Maurel , L Comps-Agrar , C Brock
NEUROPHARMACOLOGY 55 ( 4) 618 -618
2008
Structure and activation mechanism of metabotropic glutamate receptors
JP Pin , C Brock , D Maurel , L Comps-Agrar
JOURNAL OF NEUROCHEMISTRY 102 170 -170
2007
A novel, label‐free, pre‐equilibrium assay to determine the association and dissociation rate constants of therapeutic antibodies on living cells
Eric M Janezic , Alexander Doan , Elaine Mai , Daniel D Bravo
British Journal of Pharmacology
2023
Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors
Jane Grogan , Robert J Johnston , Bryan Irving , Jason Hackney
97
2018
Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors
Jane Grogan , Robert J Johnston , Bryan Irving , Jason Hackney
25
2020
Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors
Jane Grogan , Robert J Johnston , Bryan Irving , Jason Hackney
2024
Anti-interleukin-33 antibodies and uses thereof
Gerald R Nakamura , Dhaya Seshasayee , Menno Van Lookeren Campagne , WONG Tiffany
2024
Anti-interleukin-33 antibodies and uses thereof
Gerald R Nakamura , Dhaya Seshasayee , Menno Van Lookeren Campagne , WONG Tiffany
2023
Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors
Jane Grogan , Robert J Johnston , Bryan Irving , Jason Hackney
2021
TIGIT inhibits CD8+ T cell effector function during chronic viral infection and cancer (TUM7P.933)
Mahrukh Huseni , Jane Grogan , Summer Park , Jason Hackney
Journal of Immunology 192
8
2014
TIGIT mediated T cell exhaustion in cancer is dependent on TIGIT/CD226 interaction (TUM2P.907)
Mahrukh Huseni , Jane Grogan , Jason Hackney , Yagai Yang
Journal of Immunology 192
5
2014
Hyaluronic acid conjugation significantly extends the vitreal half-life of antibody fragments
Karthikan Rajagopal , C. Andrew Boswell , Amrita kamath , Kelly Loyet
Investigative Ophthalmology & Visual Science 59 ( 9) 235 -235
2018
Implementation of bioanalytical methods to quantify anti-VEGF-LAD (long acting delivery) Fabs in ocular matrices
Devin Tesar , Kelly Loyet , Laetitia Comps-Agrar , Joyce Chan
Investigative Ophthalmology & Visual Science 59 ( 9) 239 -239
2018
PK/PD modeling to identify optimal binding affinity of an intravitreally administered anti-IL33 antibody to maintain target engagement in vitreous and retina for the treatment of AMD
Menno Van Lookeren Campagne , Gerald Nakamura , Racquel Corpuz , Jack Bevers
Investigative Ophthalmology & Visual Science 59 ( 9) 246 -246
2018
Reversing HIV latency via sphingosine-1-phosphate receptor 1 signaling.
Charline Duquenne , Sandrine Gimenez , Adeline Guigues , Benjamin Viala
AIDS 31 ( 18) 2443 -2454
5
2017
PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer
Andrew M. Leader , Miriam Merad , Merone Roose-Germa , Soren Warming
Nature Reviews Cancer 1 ( 7) 681 -691
174
2020